Nvidia, AMD to pay 15% of China chip sales revenue to US govt- FT
NEW YORK - BARK, Inc. (NYSE:BARK), a dog-focused consumer products company with a market capitalization of $157 million and current stock price of $0.92, received a notice from the New York Stock Exchange (NYSE) on July 10 stating it is no longer in compliance with continued listing standards due to its stock trading below $1.00 per share over a 30-day period ending July 9, according to a company press release. According to InvestingPro analysis, the stock appears undervalued at current levels.
The NYSE notification gives BARK a six-month cure period to regain compliance, which can be achieved if the company’s stock closes at $1.00 or higher on the last trading day of any calendar month during this period and maintains an average closing price of at least $1.00 over the preceding 30 trading days.
BARK stated it intends to remain listed on the NYSE and is considering various options to address the situation, including a potential reverse stock split that would require stockholder approval.
The notice does not immediately affect BARK’s listing status, as its shares will continue to trade on the NYSE during the cure period, provided the company meets other listing requirements. The notification also does not impact BARK’s business operations or SEC reporting obligations.
Founded in 2011, BARK offers subscription-based pet products including toys and treats through its BarkBox and Super Chewer services, and sells products through retail partners including Target, Chewy, and Amazon.
In other recent news, Bark Inc. announced its Q4 2025 earnings, reporting its first-ever positive adjusted EBITDA for both the quarter and the full year. The company’s earnings per share met forecasts at $0.01, but revenue fell short of expectations at $115.4 million against a projected $126.78 million. Despite the revenue miss, Bark achieved a record gross margin of 63.6% in Q4. Analysts from Jefferies and Canaccord Genuity have adjusted their outlooks for Bark Inc., with Jefferies lowering the price target to $3.00 from $4.00 while maintaining a Buy rating, and Canaccord Genuity reducing the price target to $2.00 from $2.50, keeping a Hold rating. These adjustments follow mixed fiscal fourth-quarter results, where Bark’s revenue fell short but adjusted EBITDA exceeded forecasts. Bark has not provided full-year FY26 guidance due to ongoing challenges, but it expects adjusted EBITDA to breakeven at the midpoint for fiscal Q1. The company is also focusing on diversifying its revenue streams and mitigating tariff impacts, which have affected its marketing expenses and retail partner inventory orders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.